Related Experiment Video
Updated: Oct 20, 2025

Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation
Published on: August 8, 2025
Prosthetic valve endocarditis after transcatheter aortic valve replacement in low-risk patients
Giorgio A Medranda1, Toby Rogers1,2, Syed W Ali1
1Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, District of Columbia, USA.
Objectives:
We sought to report details of the incidence, organisms, clinical course, and outcomes of prosthetic valve endocarditis (PVE) after transcatheter aortic valve replacement (TAVR) in low-risk patients.
Background:
PVE remains a rare but devastating complication of aortic valve replacement. Data regarding PVE after TAVR in low-risk patients are lacking.
Methods:
We performed a detailed review of all patients in the low-risk TAVR trials who underwent TAVR from 2016 to 2020 and were adjudicated to have definitive PVE by the independent Clinical Events Committee.
Results:
We analyzed 396 low-risk patients who underwent TAVR (including 72 with bicuspid valves). PVE occurred in 11 patients at a median 379 days (210, 528) from TAVR. The incidence within the first 30 days was 0%; days 31-365, 1.5%; and after day 365, 2.8%. The most common organism identified was Streptococcus (n = 4/11). Early PVE (≤ 365 days) occurred in five patients, of whom three demonstrated evidence of embolic stroke and two underwent surgical aortic valve re-intervention. Late PVE (> 365 days) occurred in six patients, of whom thee demonstrated evidence of embolic stroke and only one underwent surgical aortic valve re-intervention. Of the six patients with evidence of embolic stroke, two died, two were discharged to rehabilitation, and two were discharged home with home care.
Conclusions:
PVE was infrequent following TAVR in low-risk patients but was associated with substantial morbidity and mortality. Embolic stroke complicated the majority of PVE cases, contributing to worse outcomes in these patients. Efforts must be undertaken to minimize PVE in TAVR.
Insights
Prosthetic valve endocarditis (PVE) after transcatheter aortic valve replacement (TAVR) is rare in low-risk patients but leads to significant complications, including stroke and death. Further research is needed to minimize PVE incidence and improve patient outcomes following TAVR.
Area of Science:
- Cardiology
- Interventional Cardiology
- Prosthetic Valve Endocarditis Research
Background:
- Prosthetic valve endocarditis (PVE) is a rare but serious complication following aortic valve replacement.
- Limited data exists on PVE incidence and outcomes specifically in low-risk patients undergoing transcatheter aortic valve replacement (TAVR).
Purpose of the Study:
- To investigate the incidence, causative organisms, clinical course, and outcomes of PVE in low-risk patients after TAVR.
- To provide crucial data on PVE in a population where such information is currently lacking.
Main Methods:
- A retrospective review of low-risk patients who underwent TAVR between 2016 and 2020 was conducted.
- Patients with definitive PVE, as adjudicated by an independent Clinical Events Committee, were analyzed.
Main Results:
- Out of 396 low-risk patients, 11 developed PVE at a median of 379 days post-TAVR. Incidence was 1.5% within the first year and 2.8% thereafter.
- Streptococcus was the most common organism. Early PVE (≤365 days) was associated with embolic stroke and re-intervention, while late PVE (>365 days) also frequently caused embolic stroke.
- Embolic stroke complicated the majority of PVE cases, leading to significant morbidity and mortality, including death, need for rehabilitation, or home care.
Conclusions:
- Prosthetic valve endocarditis is infrequent but carries substantial morbidity and mortality risks after TAVR in low-risk individuals.
- Embolic stroke is a major complication of PVE post-TAVR, significantly worsening patient outcomes.
- Strategies to minimize PVE incidence following TAVR are essential to improve patient prognosis.
More Related Videos
Related Concept Videos
Endocarditis I: Introduction
Endocarditis III: Medical Management
Endocarditis IV: Nursing Management
Mitral Stenosis III: Medical Management
Endocarditis II: Clinical Features of Infective Endocarditis
Mitral Valve Prolapse II: Assessment and Management

